{"id":156529,"date":"2017-10-30T15:28:02","date_gmt":"2017-10-30T15:28:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=156529"},"modified":"2017-10-30T15:28:02","modified_gmt":"2017-10-30T15:28:02","slug":"human-immunodeficiency-virus-hiv-infections-aids-global-clinical-market-trials-review-to-h2-2017-radiant-insightsinc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-market-trials-review-to-h2-2017-radiant-insightsinc_156529.html","title":{"rendered":"Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Market Trials Review To H2, 2017 | Radiant Insights,Inc"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/10\/1509356962.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/10\/1509356962.jpeg\" alt=\"\" width=\"225\" height=\"101\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Radiant Insights,Inc&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">RadiantInsights.com added Most up-to-date research on &#8220;Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017&#8221; to its huge collection of research reports.\n<\/div>\n<p style=\"text-align: justify;\">&#8220;Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017&#8221; provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &amp; E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<\/p>\n<p style=\"text-align: justify;\"><strong>View Full Report with TOC @ <\/strong><a href=\"https:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017\" target=\"_blank\">https:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Scope<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report provides a snapshot of the global clinical trials landscape<\/li>\n<li>Report provides top level data related to the clinical trials by Region, Country (G7 &amp; E7), Trial Status, Trial Phase, Sponsor Type and End point status<\/li>\n<li>The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company<\/li>\n<li>The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment<\/li>\n<li>The Report provides enrollment trends for the past five years<\/li>\n<li>Report provides latest news for the past three months<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Avail Sample Report @ <\/strong><a href=\"https:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017\/request-sample\" target=\"_blank\">https:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017\/request-sample<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Reasons To Buy<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Assists in formulating key business strategies with regards to investment<\/li>\n<li>Helps in identifying prominent locations for conducting clinical trials which saves time and cost<\/li>\n<li>Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities<\/li>\n<li>Supports understanding of trials count and enrollment trends by country in global therapeutics market<\/li>\n<li>Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials<\/li>\n<li>Facilitates clinical trial assessment of the indication on a global, regional and country level<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Explore Other Reports By Radiant Insights,Inc at<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Renal Dialysis Equipment &#8211; Medical Devices Pipeline Assessment @<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.radiantinsights.com\/research\/renal-dialysis-equipment-medical-devices-pipeline-assessment-2017\" target=\"_blank\">https:\/\/www.radiantinsights.com\/research\/renal-dialysis-equipment-medical-devices-pipeline-assessment-2017<\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>External Remote Patient Monitoring Devices &#8211; Medical Devices Pipeline Assessment @<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.radiantinsights.com\/research\/external-remote-patient-monitoring-devices-medical-devices-pipeline-assessment-2017\" target=\"_blank\">https:\/\/www.radiantinsights.com\/research\/external-remote-patient-monitoring-devices-medical-devices-pipeline-assessment-2017<\/a><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Multiparameter Patient Monitoring &#8211; Medical Devices Pipeline Assessment @<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.radiantinsights.com\/research\/multiparameter-patient-monitoring-medical-devices-pipeline-assessment-2017\" target=\"_blank\">https:\/\/www.radiantinsights.com\/research\/multiparameter-patient-monitoring-medical-devices-pipeline-assessment-2017<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About Radiant Insight<\/strong><\/p>\n<p style=\"text-align: justify;\">Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Radiant Insights, Inc.<br \/><strong>Contact Person:<\/strong> Michelle Thoras, Corporate Sales Specialist &#8211; USA<br \/><strong>Email:<\/strong> sales@radiantinsights.com<br \/><strong>Phone:<\/strong> (415) 349-0054, Toll Free: 1-888-928-9744 <br \/><strong>Address:<\/strong>201 Spear Street 1100, Suite 3036  <br \/><strong>City:<\/strong> San Francisco<br \/><strong>State:<\/strong> California<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017\" target=\"_blank\" rel=\"nofollow\">www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.radiantinsights.com\/research\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=human-immunodeficiency-virus-hiv-infections-aids-global-clinical-market-trials-review-to-h2-2017-radiant-insightsinc\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Radiant Insights,Inc&#8221; RadiantInsights.com added Most up-to-date research on &#8220;Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017&#8221; to its huge collection of research reports. &#8220;Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017&#8221; provides &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-market-trials-review-to-h2-2017-radiant-insightsinc_156529.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-156529","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/156529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=156529"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/156529\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=156529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=156529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=156529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}